Pre-clinical evaluation of novel anti-tuberculosis molecules


Tuberculosis (TB) currently represents a major global health concern, especially when considering the emergence of multidrug-resistant strains of Mycobacterium tuberculosis. On this regard, the identification of new effective agents to treat this infectious disease is urgently needed. Herein, we describe the pre-clinical assays on the anti-tubercular… (More)


Cite this paper

@inproceedings{Campos2014PreclinicalEO, title={Pre-clinical evaluation of novel anti-tuberculosis molecules}, author={Maria Martha Campos}, year={2014} }